SE8002910L - 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar - Google Patents
3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomarInfo
- Publication number
- SE8002910L SE8002910L SE8002910A SE8002910A SE8002910L SE 8002910 L SE8002910 L SE 8002910L SE 8002910 A SE8002910 A SE 8002910A SE 8002910 A SE8002910 A SE 8002910A SE 8002910 L SE8002910 L SE 8002910L
- Authority
- SE
- Sweden
- Prior art keywords
- preparation
- chronic obstructive
- treatment
- sup
- dialkylxantines
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 208000024172 Cardiovascular disease Diseases 0.000 title abstract 3
- 238000002360 preparation method Methods 0.000 title abstract 3
- 238000011282 treatment Methods 0.000 title abstract 2
- 230000001684 chronic effect Effects 0.000 title 1
- 230000000414 obstructive effect Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 3
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 2
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 2
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 abstract 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 2
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 abstract 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 abstract 1
- 125000004210 cyclohexylmethyl group Chemical group [H]C([H])(*)C1([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 abstract 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
- C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- General Health & Medical Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Saccharide Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Priority Applications (21)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8002910A SE8002910L (sv) | 1980-04-18 | 1980-04-18 | 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar |
| EP81850039A EP0038784B1 (en) | 1980-04-18 | 1981-03-09 | 3,8-dialkylxanthines, processes for their preparation and compositions containing them |
| AT81850039T ATE10099T1 (de) | 1980-04-18 | 1981-03-09 | 3,8-dialkylxanthine, verfahren zu ihrer herstellung und diese enthaltende zusammensetzungen. |
| DE8181850039T DE3166893D1 (en) | 1980-04-18 | 1981-03-09 | 3,8-dialkylxanthines, processes for their preparation and compositions containing them |
| ZA00811729A ZA811729B (en) | 1980-04-18 | 1981-03-16 | 3,8-dialkyixanthines, their preparation and use |
| CA000373230A CA1156229A (en) | 1980-04-18 | 1981-03-17 | 3.8-dialkylxanthines, processes for their preparation, composition and methods for the treatment of chronic obstructive airway disease and cardiovascular diseases |
| PH25455A PH16264A (en) | 1980-04-18 | 1981-04-01 | 3,8-dialkylxanthines,their compositions and methods for the treatment of chromic obstructive airway disease and cardiovascular diseases |
| NO811161A NO811161L (no) | 1980-04-18 | 1981-04-03 | 3,8-dialkylxantiner og fremgangsmaate for deres fremstilling |
| IE769/81A IE51106B1 (en) | 1980-04-18 | 1981-04-08 | 3,8-dialkylxanthines,processes for their preparation and compositions containing them |
| DK168281AA DK151631B (da) | 1980-04-18 | 1981-04-14 | Analogifremgangsmaade til fremstilling af 3,8-dialkylxantiner. |
| DD81229229A DD158400A5 (de) | 1980-04-18 | 1981-04-14 | Verfahren zur herstellung von 3,8-dialkylxanthinen |
| AU69555/81A AU543122B2 (en) | 1980-04-18 | 1981-04-15 | Purines |
| GR64702A GR82347B (sv) | 1980-04-18 | 1981-04-15 | |
| NZ196829A NZ196829A (en) | 1980-04-18 | 1981-04-15 | Certain 3,8-disubstituted-3,7-dihydro-1h-purine-2,6-diones |
| ES501400A ES501400A0 (es) | 1980-04-18 | 1981-04-15 | Un metodo para la preparacion de 3,8-dialcohilxantinas |
| FI811212A FI69465C (fi) | 1980-04-18 | 1981-04-16 | Foerfarande foer framstaellning av farmakologiskt aktiva 3,8-dialkylxantiner |
| PT72881A PT72881B (en) | 1980-04-18 | 1981-04-16 | Process for preparing 3,8-dialkylxanthines and pharmaceutical compositions thereof useful for the treatment of chronic obstructive airway disease and cardiovascular diseases |
| JP5724181A JPS56166191A (en) | 1980-04-18 | 1981-04-17 | 3,8-dialkylxanthines and manufacture |
| PL1981230737A PL134762B1 (en) | 1980-04-18 | 1981-04-17 | Method of obtaining novel 3,8-dialkyloxantines |
| HU811020A HU185254B (en) | 1980-04-18 | 1981-04-17 | Process for preparing 3,8-dialkyl-xanthines |
| US06/523,731 US4546182A (en) | 1980-04-18 | 1983-08-16 | 3,8-Dialkylxanthines |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE8002910A SE8002910L (sv) | 1980-04-18 | 1980-04-18 | 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SE8002910L true SE8002910L (sv) | 1981-10-19 |
Family
ID=20340763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE8002910A SE8002910L (sv) | 1980-04-18 | 1980-04-18 | 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US4546182A (sv) |
| EP (1) | EP0038784B1 (sv) |
| JP (1) | JPS56166191A (sv) |
| AT (1) | ATE10099T1 (sv) |
| AU (1) | AU543122B2 (sv) |
| CA (1) | CA1156229A (sv) |
| DD (1) | DD158400A5 (sv) |
| DE (1) | DE3166893D1 (sv) |
| DK (1) | DK151631B (sv) |
| ES (1) | ES501400A0 (sv) |
| FI (1) | FI69465C (sv) |
| GR (1) | GR82347B (sv) |
| HU (1) | HU185254B (sv) |
| IE (1) | IE51106B1 (sv) |
| NO (1) | NO811161L (sv) |
| NZ (1) | NZ196829A (sv) |
| PH (1) | PH16264A (sv) |
| PL (1) | PL134762B1 (sv) |
| PT (1) | PT72881B (sv) |
| SE (1) | SE8002910L (sv) |
| ZA (1) | ZA811729B (sv) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7810947L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | 3-alkylxanthines |
| US4710503A (en) * | 1985-02-07 | 1987-12-01 | Euroceltique S.A. | 6-thioxanthine derivatives |
| GB8618931D0 (en) * | 1986-08-02 | 1986-09-10 | Euro Celtique Sa | 6-thioxanthines |
| US5298508A (en) * | 1988-07-19 | 1994-03-29 | The United States Of America As Represented By The Department Of Health And Human Services | Irreversible inhibitors of adenosine receptors |
| JP2843634B2 (ja) * | 1989-03-06 | 1999-01-06 | 協和醗酵工業株式会社 | キサンチン誘導体 |
| IT1229195B (it) * | 1989-03-10 | 1991-07-25 | Poli Ind Chimica Spa | Derivati xantinici ad attivita' broncodilatatrice e loro applicazioni terapeutiche. |
| AU5436790A (en) * | 1989-04-19 | 1990-11-16 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | Sulfer-containing xanthine derivatives as adenosin antagonists |
| CA2030112A1 (en) * | 1989-11-24 | 1991-05-25 | Yasuo Ito | Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same |
| US5366977A (en) * | 1992-09-29 | 1994-11-22 | The United States Of America, As Represented By The Department Of Health And Human Services | Method of treating cystic fibrosis using 8-cyclopentyl-1,3-dipropylxanthine or xanthine amino congeners |
| DE4311538C1 (de) * | 1993-04-07 | 1994-10-06 | Boehringer Ingelheim Kg | Verfahren zur Herstellung von 1,3-Dimethyl-4,5-diaminouracil |
| WO1994025462A1 (en) * | 1993-05-03 | 1994-11-10 | The United States Of America, Represented By The | 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists |
| US6316423B1 (en) | 1996-04-10 | 2001-11-13 | The United States Of America As Represented By The Departmant Of Health And Human Services | Method of treating ischemic, hypoxic and anoxic brain damage |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS53890B2 (sv) * | 1972-04-22 | 1978-01-12 | ||
| CA1077932A (en) * | 1976-03-31 | 1980-05-20 | Berlex Laboratories, Inc. | Xanthine compounds and method of treating bronchospastic and allergic diseases |
| US4089959A (en) * | 1976-03-31 | 1978-05-16 | Cooper Laboratories, Inc. | Long-acting xanthine bronchodilators and antiallergy agents |
| SE416810C (sv) * | 1977-10-14 | 1982-07-19 | Draco Ab | Forfarande for framstellning av xantinderivat med antiallergisk aktivitet |
| SE7810947L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | 3-alkylxanthines |
| SE7810946L (sv) * | 1978-10-20 | 1980-04-21 | Draco Ab | Metod att behandla kronisk obstruktiv luftvegssjukdom |
-
1980
- 1980-04-18 SE SE8002910A patent/SE8002910L/sv not_active Application Discontinuation
-
1981
- 1981-03-09 DE DE8181850039T patent/DE3166893D1/de not_active Expired
- 1981-03-09 AT AT81850039T patent/ATE10099T1/de not_active IP Right Cessation
- 1981-03-09 EP EP81850039A patent/EP0038784B1/en not_active Expired
- 1981-03-16 ZA ZA00811729A patent/ZA811729B/xx unknown
- 1981-03-17 CA CA000373230A patent/CA1156229A/en not_active Expired
- 1981-04-01 PH PH25455A patent/PH16264A/en unknown
- 1981-04-03 NO NO811161A patent/NO811161L/no unknown
- 1981-04-08 IE IE769/81A patent/IE51106B1/en unknown
- 1981-04-14 DK DK168281AA patent/DK151631B/da active IP Right Grant
- 1981-04-14 DD DD81229229A patent/DD158400A5/de unknown
- 1981-04-15 NZ NZ196829A patent/NZ196829A/en unknown
- 1981-04-15 GR GR64702A patent/GR82347B/el unknown
- 1981-04-15 ES ES501400A patent/ES501400A0/es active Granted
- 1981-04-15 AU AU69555/81A patent/AU543122B2/en not_active Ceased
- 1981-04-16 FI FI811212A patent/FI69465C/fi not_active IP Right Cessation
- 1981-04-16 PT PT72881A patent/PT72881B/pt unknown
- 1981-04-17 JP JP5724181A patent/JPS56166191A/ja active Pending
- 1981-04-17 HU HU811020A patent/HU185254B/hu unknown
- 1981-04-17 PL PL1981230737A patent/PL134762B1/pl unknown
-
1983
- 1983-08-16 US US06/523,731 patent/US4546182A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| FI69465C (fi) | 1986-02-10 |
| ES8203088A1 (es) | 1982-02-16 |
| FI811212L (fi) | 1981-10-19 |
| PL230737A1 (sv) | 1982-03-29 |
| US4546182A (en) | 1985-10-08 |
| PL134762B1 (en) | 1985-09-30 |
| CA1156229A (en) | 1983-11-01 |
| NO811161L (no) | 1981-10-19 |
| ZA811729B (en) | 1982-04-28 |
| EP0038784B1 (en) | 1984-10-31 |
| ATE10099T1 (de) | 1984-11-15 |
| DK168281A (da) | 1981-10-19 |
| DD158400A5 (de) | 1983-01-12 |
| EP0038784A2 (en) | 1981-10-28 |
| DK151631B (da) | 1987-12-21 |
| GR82347B (sv) | 1984-12-13 |
| ES501400A0 (es) | 1982-02-16 |
| PH16264A (en) | 1983-08-23 |
| AU6955581A (en) | 1981-10-22 |
| PT72881B (en) | 1983-03-29 |
| IE810796L (en) | 1981-10-18 |
| AU543122B2 (en) | 1985-04-04 |
| FI69465B (fi) | 1985-10-31 |
| PT72881A (en) | 1981-05-01 |
| HU185254B (en) | 1984-12-28 |
| JPS56166191A (en) | 1981-12-21 |
| DE3166893D1 (en) | 1984-12-06 |
| IE51106B1 (en) | 1986-10-01 |
| EP0038784A3 (en) | 1982-01-20 |
| NZ196829A (en) | 1984-12-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0011609A3 (en) | Method and pharmaceutical preparation for treating chronic obstructive airway disease and cardiac disease, and intermediates for the preparation of therapeutically active xanthine derivatives | |
| SE8002910L (sv) | 3,8-dialkylxantiner, forfarande for deras framstellning, beredning och metoder for behandling av kronisk obstruktiv luftvegssjukdom och kardiovaskulera sjukdomar | |
| MY102565A (en) | Novel derivatives of guanine | |
| DE3268041D1 (en) | Pharmaceutical preparations containing vicinal dihydroxyalkyl xanthines, process for the preparation of the xanthines and the appropriate intermediates therefor | |
| EP0138344A3 (en) | Pyridazinones as beta-adrenoceptor antagonists | |
| DE3462894D1 (de) | 3-indolecarboxamide compounds | |
| PT76934A (en) | Process for the preparation of novel cetene-thio-acetals | |
| IT8121884A0 (it) | Procedimento per la sintesi di esteri dell'acido carbonico derivanti da alcoli insaturi ed alcoli poliidrici. | |
| DE3277971D1 (en) | Acylamino-4-aza-1-adamantanes, process for their preparation and their therapeutic use | |
| IE832787L (en) | Polyether compounds. | |
| RO78451A (ro) | Procedeu de obtinere a unui medicament imunobioterapeutic impotriva maladiilor infectioase ale cailor respiratorii | |
| CA942671A (en) | Inhalant compositions for treatment of obstructive diseases of the respiratory tract | |
| JPS5780321A (en) | Cardiotonic agent | |
| IT8223517A0 (it) | Procedimento per la preparazione di esteri dell'acido vincaminico. | |
| ES8706140A1 (es) | Procedimiento para preparar derivados de flaveno y tioflaveno | |
| IT1210984B (it) | Procedimento per la preparazione di un derivato dell'acido acetico. | |
| ES8502128A1 (es) | Procedimiento para la preparacion de derivados de 6 -metilprednisolona | |
| IT8219330A0 (it) | Composto medicinale per il trattamento di malattie di cuore. | |
| IT7868862A0 (it) | Composto epossidico alifatico per usi terapeutici particolarmente per la cura di affezioni prostatiche |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAV | Patent application has lapsed |
Ref document number: 8002910-1 |